Kukje Pharma Co., Ltd. (KRX:002720)

Kukje Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	98,351	103,034	119,890	106,115	112,861	176,865
Market Cap Growth	-24.89%	-14.06%	12.98%	-5.98%	-36.19%	118.14%
Enterprise Value	117,896	124,008	140,751	127,215	143,804	207,752
Last Close Price	4830.00	5028.54	5883.19	5205.53	5534.53	8670.51
PE Ratio	22.82	19.80	-	29.83	-	80.28
PS Ratio	0.61	0.66	0.89	0.84	0.94	1.36
PB Ratio	1.08	1.15	1.41	1.43	1.65	2.51
P/TBV Ratio	1.09	1.16	1.43	1.45	1.67	2.54
P/FCF Ratio	540.30	100.14	47.40	20.23	14.65	-
P/OCF Ratio	29.76	26.15	33.53	16.32	11.76	34.68
EV/Sales Ratio	0.73	0.79	1.04	1.00	1.20	1.59
EV/EBITDA Ratio	13.42	12.52	63.55	13.03	52.42	21.49
EV/EBIT Ratio	21.02	18.50	-	24.13	-	34.39
EV/FCF Ratio	647.67	120.53	55.65	24.26	18.66	-
Debt / Equity Ratio	0.33	0.33	0.36	0.39	0.53	0.54
Debt / EBITDA Ratio	3.35	2.98	13.84	2.93	13.12	3.94
Debt / FCF Ratio	161.88	28.68	12.12	5.45	4.67	-
Asset Turnover	0.98	0.95	0.90	0.92	0.84	0.93
Inventory Turnover	3.57	3.39	3.14	3.27	3.42	3.43
Quick Ratio	1.41	1.13	0.53	0.54	0.58	0.51
Current Ratio	2.44	2.00	0.92	1.01	0.88	0.90
Return on Equity (ROE)	4.81%	5.97%	-10.58%	4.97%	-2.24%	3.34%
Return on Assets (ROA)	2.13%	2.55%	-0.83%	2.38%	-0.73%	2.70%
Return on Capital (ROIC)	2.93%	3.57%	-1.14%	3.18%	-0.98%	3.68%
Return on Capital Employed (ROCE)	4.00%	4.90%	-	5.90%	-	6.70%
Earnings Yield	4.38%	5.05%	-7.02%	3.35%	-1.38%	1.25%
FCF Yield	0.19%	1.00%	2.11%	4.94%	6.83%	-3.67%
Dividend Yield	0.62%	0.60%	-	-	-	-
Payout Ratio	14.17%	-	-	-	-	-
Buyback Yield / Dilution	-0.28%	-0.53%	0.03%	0.03%	0.03%	0.00%
Total Shareholder Return	0.34%	0.07%	0.03%	0.03%	0.03%	0.00%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.